Search clinical trials for: sacral nerve modulation

Total 139974 results

Hadassah Medical Organization

Unknown

Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers

Smoking | Tobacco Use Disorder | Nicotine Dependence | Nicotine Use Disorder

Israel
DOV Pharmaceutical, Inc.

Completed

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Chronic Low Back Pain
Fredericia Hosptial

Unknown

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

Kidney Stone | Ureteroscopy

Denmark
Odense University Hospital

Completed

OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models

Healthy

Denmark
Helicor

Unknown

Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia

Primary Insomnia

United States
Hospital de Clinicas de Porto Alegre

Unknown

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Diabetes Mellitus | Microalbuminuria

Brazil
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Schizophrenia | Schizoaffective Disorder | Social Anxiety Disorder

United States
University of Medicine and Dentistry of New Jersey
National Alliance for Autism Research

Completed

Galantamine Versus Placebo in Childhood Autism

Autism | Childhood Autism

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Memorial Sloan Kettering Cancer Center

Completed

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery

Prostate Cancer

United States
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Inappropriate ADH Syndrome | Water Intoxication | Hyponatremias | Water-Electrolyte Imbalances

United States
Eli Lilly and Company

Completed

A Study of LY317615 in Patients With Brain Tumors

Malignant Glioma

United States
Northeastern Ohio Universities College of Medicine
Pfizer; U.S. Army Medical Research and Development Command; Louis Stokes VA Medical... and other collaborators

Unknown

Restless Legs Syndrome Exercise Intervention

Restless Legs Syndrome | Insomnia
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company

Completed

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
University of Texas Southwestern Medical Center
Biogen

Completed

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Multiple Sclerosis

United States
Università degli Studi dell'Insubria

Unknown

Open Lung Approach During General Anaesthesia to Prevent Post-Operative Pulmonary Complications

Postoperative Complications

Italy
National Center for Complementary and Integrative...

Completed

Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)

Temporomandibular Disorders

United States
Sheba Medical Center

Unknown

T-Cell Vaccination in Multiple Sclerosis (MS)

Multiple Sclerosis

Israel
Sheba Medical Center

Unknown

Early Movements as a Predictor of Future Developmental Delay

Cerebral Palsy | Premature Birth

Israel
China Medical University Hospital

Unknown

Effect of Electroacupuncture in Diabetic Patients With Gastroparesis

Diabetes Mellitus | Gastroparesis

Taiwan
National Center for Complementary and Integrative...

Completed

Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System

Vestibular Neuronitis | Vestibulopathy

United States
BZL Biologics

Completed

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Prostatic Neoplasms

United States
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Memory Disorders | Delirium, Dementia, Amnestic, Cognitive Disorders

Netherlands
Charite University, Berlin, Germany

Terminated

Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Germany
Indiana University School of Medicine

Terminated

Galantamine Augmentation of Escitalopram for Treatment of Depression

Depression

United States
University Medicine Greifswald
German Federal Ministry of Education and Research

Completed

Motivation in Alcohol Treatment Facilities

Alcohol Dependence | Alcohol Abuse

Germany

Search clinical trials for: sacral nerve modulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations